Education
About Us
Working with TipRanks
Follow Us
Tandem Diabetes Care (TNDM)
NASDAQ:TNDM
Total Valuation
Tandem Diabetes Care has a market cap or net worth of $1.54B. The enterprise value is $1.97B.
Market Cap$1.54B
Enterprise Value$1.97B
Share Statistics
Tandem Diabetes Care has 66,607,210 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding66,607,210
Owned by Insiders0.82%
Owned by Institutions0.02%
Financial Efficiency
Tandem Diabetes Care’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -13.61%.
Return on Equity (ROE)-0.36
Return on Assets (ROA)-0.10
Return on Invested Capital (ROIC)-13.61%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee354.79K
Profits Per Employee-36.24K
Employee Count2,650
Asset Turnover0.97
Inventory Turnover3.01
Valuation Ratios
The current PE Ratio of Tandem Diabetes Care is -24.55. Tandem Diabetes Care’s PEG ratio is 0.09.
PE Ratio-24.55
PS Ratio0.00
PB Ratio9.83
Price to Fair Value8.96
Price to FCF-30.49
Price to Operating Cash Flow109.44
PEG Ratio0.09
Income Statement
In the last 12 months, Tandem Diabetes Care had revenue of 940.20M and earned -96.03M in profits. Earnings per share was -1.47.
Revenue940.20M
Gross Profit489.57M
Operating Income-99.13M
Pretax Income-91.87M
Net Income-96.03M
EBITDA-99.13M
Earnings Per Share (EPS)-1.47
Cash Flow
In the last 12 months, operating cash flow was 13.94M and capital expenditures -64.14M, giving a free cash flow of -50.20M billion.
Operating Cash Flow13.94M
Free Cash Flow-50.20M
Free Cash Flow per Share-0.75
Dividends & Yields
Tandem Diabetes Care pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.36
52-Week Price Change-51.13%
50-Day Moving Average19.19
200-Day Moving Average31.87
Relative Strength Index (RSI)66.82
Average Volume (3m)1.76M
Important Dates
Tandem Diabetes Care upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.
Last Earnings DateApr 30, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend Date―
Financial Position
Tandem Diabetes Care as a current ratio of 2.93, with Debt / Equity ratio of 317.60%
Current Ratio2.93
Quick Ratio2.33
Debt to Market Cap0.15
Net Debt to EBITDA-4.08
Interest Coverage Ratio-13.37
Taxes
In the past 12 months, Tandem Diabetes Care has paid 4.16M in taxes.
Income Tax4.16M
Effective Tax Rate-0.05
Enterprise Valuation
Tandem Diabetes Care EV to EBITDA ratio is -27.86, with an EV/FCF ratio of 553.04.
EV to Sales2.94
EV to EBITDA-27.86
EV to Free Cash Flow553.04
EV to Operating Cash Flow114.01
Balance Sheet
Tandem Diabetes Care has $368.63M in cash and marketable securities with $493.20M in debt, giving a net cash position of $124.58M billion.
Cash & Marketable Securities$368.63M
Total Debt$493.20M
Net Cash$124.58M
Net Cash Per Share$1.87
Tangible Book Value Per Share$4.01
Margins
Gross margin is 46.57%, with operating margin of -10.54%, and net profit margin of -10.21%.
Gross Margin46.57%
Operating Margin-10.54%
Pretax Margin-9.77%
Net Profit Margin-10.21%
EBITDA Margin-10.54%
EBIT Margin-10.56%
Analyst Forecast
The average price target for Tandem Diabetes Care is $34.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$34.75
Price Target Upside50.56% Upside
Analyst ConsensusModerate Buy
Analyst Count16
Revenue Growth Forecast27.65%
EPS Growth Forecast-28.22%